Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,036 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 965
Recruiting: 553
Ph III recruiting: 55
Growth YoY: +9.2%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (701)

clinicaltrialsPublishedShowing 151–200 of 395 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00710892	CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene(CASPALLO)	active not recruiting	Phase 1	10	Baylor College of MedicineOTHER	1	Jul 1, 2026	clinicaltrials
NCT01494103	Administration of Donor T Cells With the Caspase-9 Suicide Gene(DOTTI)	active not recruiting	Phase 1	15	Baylor College of MedicineOTHER	1	Jul 1, 2026